Poseida Therapeutics
Mr. Corning is Portfolio Manager and Head of Credit at Pentwater Capital Management. He currently manages the credit team at Pentwater, where he has held several key positions since 2014. Prior to this role, he spent eight years as the senior investment professional at a private Chicago-based proprietary trading and investment firm. Mr. Corning began his career as an analyst at Goldman, Sachs & Co. in 2004. He holds a B.S. in finance from Miami University of Ohio, and is an alumnus of the Program for Leadership Development at Harvard Business School. Mr. Corning serves on a number of boards of directors, including Malin Corporation, Plc, one of Poseida’s early investors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into life-saving cell and gene therapies for patients with high unmet medical needs.